Stay Informed!

Sign up for one
of our newsletters.

Garnette Sutherland – 2024 Research Grant Recipient

Generously funded by Donors of Brain Tumour Foundation of Canada

Garnette SutherlandGarnette Sutherland – University of Calgary – Calgary, Alta.

Project title: “Artificial intelligence for early diagnosis and prognostication for meningioma”

Description of project:

Meningioma is the most common primary brain tumour in adults. Although a large percentage are classified as benign, the more aggressive types of meningioma impose a significant morbidity and mortality burden on patients. Molecular analyses of these tumours help with accurate prognostication, however, performing molecular analysis is costly and difficult for resource-challenged centers, even in developed nations. A tool to identify the meningiomas’ genetics and aggressiveness before surgery can help in surgical planning and post-operative management for better patient-specific treatment strategies. Artificial intelligence (AI) offers great promise for this purpose. Although magnetic resonance imaging (MRI) contains a plethora of pixel data that is invisible to the naked eye, AI algorithms can rapidly process and decipher thousands of image pixels.

What receiving this award means:

The support by Brain Tumour Foundation of Canada will be a catalyst towards an online prediction model, built on population-based molecular characterization of meningioma, that includes imaging and patient demography. Built upon a unique dynamic digital database (using a knowledge graph) and custom machine learning algorithms, this tool will provide valuable insight for clinicians, scientists and patients.

Brain Tumour Foundation of Canada
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.